Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4608764

COc1cc(NC(=O)c2ccccc2)c(OC)cc1[N+]#N.[Cl-]

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.67
▸ KMT2A Q03164 7/20 0.67
▸ SMN1; SMN2 Q16637 2/20 0.64
▸ ALDH1A1 P00352 2/20 0.64
▸ MAPK1 P28482 2/20 0.62
▸ MAPT P10636 2/20 0.62
▸ AHR P35869 1/20 0.62
▸ KDM4E B2RXH2 2/20 0.56
▸ HSD17B10 Q99714 1/20 0.56
▸ HDAC1 Q13547 1/20 0.55
▸ HDAC8 Q9BY41 1/20 0.55
▸ HDAC6 Q9UBN7 1/20 0.55
▸ POLB P06746 1/20 0.53
▸ THRB P10828 1/20 0.53
▸ RECQL P46063 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ CTDSP1 Q9GZU7 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10973722 0.99 MEN1 (0.68) MEN1KMT2ASMN1; SMN2ALDH1A1MAPK1
Zinc Chloride SCHEMBL30135274 0.95 MEN1 (0.61) MEN1KMT2ASMN1; SMN2ALDH1A1MAPK1
Hydrochloric Acid SCHEMBL11693570 0.95 MEN1 (0.63) MEN1KMT2ASMN1; SMN2ALDH1A1MAPK1
SCHEMBL11690434 0.94 MEN1 (0.62) MEN1KMT2ASMN1; SMN2ALDH1A1MAPK1
SCHEMBL27922925 0.89 MAPT (0.61) MEN1KMT2ASMN1; SMN2ALDH1A1MAPK1
SCHEMBL9653899 0.88 MEN1 (0.58) MEN1KMT2ASMN1; SMN2ALDH1A1MAPK1
Trifluoromethanesulfonic Acid SCHEMBL11057927 0.88 MEN1 (0.60) MEN1KMT2ASMN1; SMN2ALDH1A1MAPK1
SCHEMBL11081067 0.87 MEN1 (0.60) MEN1KMT2ASMN1; SMN2ALDH1A1MAPK1
SCHEMBL14588703 0.87 MEN1 (0.56) MEN1KMT2ASMN1; SMN2ALDH1A1MAPK1
SCHEMBL11427553 0.84 MEN1 (0.53) MEN1KMT2ASMN1; SMN2ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1113779-A1 METHOD FOR DYEING FIBRES CONTAINING KERATIN USING STABLE DIAZONIUM SALTS Henkel Kommanditgesellschaft auf Aktien (DE) 2001-07-11 — — EP claimed
WO-2000015184-A1 METHOD FOR DYEING FIBRES CONTAINING KERATIN USING STABLE DIAZONIUM SALTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2000-03-23 — — WO claimed
US-20240003922-A1 POLYMERIC GEL COMPOSITIONS FOR DETECTION OF THC Genesee Valley Innovations, LLC 2024-01-04 — — US disclosed
US-9791399-B2 Derivatization of carbon SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2017-10-17 — — US disclosed
US-20140332412-A1 DERIVATIZATION OF CARBON SCHLUMBERGER TECHNOLOGY COPORATION (US) 2014-11-13 — — US disclosed
WO-2014096232-A1 PROCESS OF ELECTROCHEMICALLY REDUCING AN AROMATIC DIAZONIUM SALT ON A SUBSTRATE AND SUBSTRATE OBTAINED THEREBY NATIONAL UNIVERSITY OF IRELAND MAYNOOTH (IE) 2014-06-26 — — WO disclosed
WO-2013093882-A2 DERIVATIZATION OF CARBON SCHLUMBERGER TECHNOLOGY B.V. (NL) 2013-06-27 — — WO disclosed
EP-1517668-B1 GENTLE OXIDATIVE HAIR DYEING METHODS HENKEL AG & CO KGAA (DE) 2008-10-08 — — EP disclosed
EP-1517668-A2 GENTLE OXIDATIVE HAIR DYING METHODS Henkel Kommanditgesellschaft auf Aktien (DE) 2005-03-30 — — EP disclosed
WO-2004002439-A2 GENTLE OXIDATIVE HAIR DYING METHODS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-01-08 — — WO disclosed
EP-1220654-A1 HAIR COLORATION METHOD Henkel Kommanditgesellschaft auf Aktien (DE) 2002-07-10 — — EP disclosed
EP-1113779-A1 METHOD FOR DYEING FIBRES CONTAINING KERATIN USING STABLE DIAZONIUM SALTS Henkel Kommanditgesellschaft auf Aktien (DE) 2001-07-11 — — EP disclosed
WO-2001026616-A1 HAIR COLORATION METHOD HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-04-19 — — WO disclosed
WO-2000015184-A1 METHOD FOR DYEING FIBRES CONTAINING KERATIN USING STABLE DIAZONIUM SALTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2000-03-23 — — WO disclosed
EP-0410750-B1 Use of Interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia. SCHERING CORP (US) 1995-03-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140332412-A1 DERIVATIZATION OF CARBON FTH1, CBR1, SDHB MEN1 1759/4885KMT2A 961/4885SMN1; SMN2 4435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback